Skip to main content

Table 1 Patient clinical characteristic.

From: Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose

Patient

Age (years)

Sex

Cancer

1

70

M

Prostate

2

76

M

Prostate

3

56

M

Prostate

4

68

M

Prostate

5

65

M

Prostate

6

74

M

Prostate

7

61

M

Prostate

8

65

M

Prostate

9

66

F

Breast

10

34

F

Breast

11

42

F

Cervix

12

51

F

Breast

13

69

F

Breast

14

72

M

Unknown primitive cancer

15

64

F

Breast

16

62

M

Prostate

17

62

M

Prostate

18

74

M

Medullar Thyroid

19

54

M

Prostate

20

77

F

Breast

21

50

F

Breast

  1. mean value ± standard deviation = 62 ± 11 years